OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunogenic Cell Death in Hematological Malignancy Therapy
Zhaoyun Liu, Xintong Xu, Kaining Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 13
Open Access | Times Cited: 29
Zhaoyun Liu, Xintong Xu, Kaining Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 13
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Activated aggregation‐induced emission therapeutics agents for triggering regulated cell death
Yu‐Qiang Zhao, Le Yu, Lanyun Zhang, et al.
Aggregate (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 12
Yu‐Qiang Zhao, Le Yu, Lanyun Zhang, et al.
Aggregate (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 12
Metal-sensitized Au-Bi2O3 nanoheterojunction for immunogenic cell death-boosted sono-immuno cancer therapy
Guobo Chen, Jun Du, Liping Gu, et al.
Chemical Engineering Journal (2024) Vol. 482, pp. 148953-148953
Closed Access | Times Cited: 10
Guobo Chen, Jun Du, Liping Gu, et al.
Chemical Engineering Journal (2024) Vol. 482, pp. 148953-148953
Closed Access | Times Cited: 10
Multivalence Manganese Mediated Dual ROS Generator for Augmented Chemodynamic Therapy and Activated Antitumor Immunogenic Responses
Linlin Huo, Shiqi Zhu, Jie Zeng, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 3, pp. 885-895
Closed Access | Times Cited: 9
Linlin Huo, Shiqi Zhu, Jie Zeng, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 3, pp. 885-895
Closed Access | Times Cited: 9
Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot
Yiman Han, Xin Tian, Jiaqi Zhai, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 9
Yiman Han, Xin Tian, Jiaqi Zhai, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 9
Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer
Xin Jin, Wenke Jin, L. Tong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2815-2853
Open Access | Times Cited: 8
Xin Jin, Wenke Jin, L. Tong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2815-2853
Open Access | Times Cited: 8
DNA origami-based composite nanosandwich for iteratively potentiated chemo-immunotherapy
Mengyue Li, Hanxi Zhang, Peizheng Xiong, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 452-465
Closed Access | Times Cited: 1
Mengyue Li, Hanxi Zhang, Peizheng Xiong, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 452-465
Closed Access | Times Cited: 1
Biological effects of metal-based nanomaterials for tumor metalloimmunotherapy
Huali Lei, Guanghui Hou, Minjiang Chen, et al.
Nano Today (2023) Vol. 53, pp. 102033-102033
Closed Access | Times Cited: 17
Huali Lei, Guanghui Hou, Minjiang Chen, et al.
Nano Today (2023) Vol. 53, pp. 102033-102033
Closed Access | Times Cited: 17
Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems
Jianlan Peng, Shiying Li, Huihui Ti
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 5895-5930
Open Access | Times Cited: 5
Jianlan Peng, Shiying Li, Huihui Ti
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 5895-5930
Open Access | Times Cited: 5
Engineering Dual‐Responsive Prodrug‐MOFs as Immunogenic Cell Death Initiator for Enhancing Cancer Immunotherapy
Xiaochun Hu, Ruihao Li, Jie Liu, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 7
Closed Access | Times Cited: 4
Xiaochun Hu, Ruihao Li, Jie Liu, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 7
Closed Access | Times Cited: 4
Shifting cold to hot tumors by nanoparticle-loaded drugs and products
Irfan Ahmad, Kamil K. Atiyah Altameemi, Mohaned Mohammed Hani, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 4
Irfan Ahmad, Kamil K. Atiyah Altameemi, Mohaned Mohammed Hani, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 4
Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity
Ziyu Guo, Yihuang Liu, Danyao Chen, et al.
Journal of Translational Internal Medicine (2025) Vol. 13, Iss. 1, pp. 10-32
Closed Access
Ziyu Guo, Yihuang Liu, Danyao Chen, et al.
Journal of Translational Internal Medicine (2025) Vol. 13, Iss. 1, pp. 10-32
Closed Access
Liposomes as Immunotherapeutic Carriers: A Game-Changer in Cancer Therapy
Sepehr Hoseinzadeh Moghaddam, Abulfazl Vatankhah, Fatemeh Oroojalian, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106847-106847
Closed Access
Sepehr Hoseinzadeh Moghaddam, Abulfazl Vatankhah, Fatemeh Oroojalian, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106847-106847
Closed Access
A CXCR4-targeted immunomodulatory nanomedicine for photodynamic amplified immune checkpoint blockade therapy against breast cancer
Yibin Liu, Xiayun Chen, Wei Zhang, et al.
Acta Biomaterialia (2025)
Closed Access
Yibin Liu, Xiayun Chen, Wei Zhang, et al.
Acta Biomaterialia (2025)
Closed Access
Hypoxia-responsive oncolytic conjugate triggers type-II immunogenic cell death for enhanced photodynamic immunotherapy
Maomao Ren, Xin Sun, Jiayi Lin, et al.
Journal of Controlled Release (2025), pp. 113717-113717
Closed Access
Maomao Ren, Xin Sun, Jiayi Lin, et al.
Journal of Controlled Release (2025), pp. 113717-113717
Closed Access
Targeting neutrophils potentiates hitchhiking delivery of drugs and agonists for postsurgical chemo-immunotherapy
Zhiliang Gao, Ning Wang, Yuan Ma, et al.
Nano Today (2023) Vol. 54, pp. 102096-102096
Closed Access | Times Cited: 9
Zhiliang Gao, Ning Wang, Yuan Ma, et al.
Nano Today (2023) Vol. 54, pp. 102096-102096
Closed Access | Times Cited: 9
Acid-Activated TAT Peptide-Modified Biomimetic Boron Nitride Nanoparticles for Enhanced Targeted Codelivery of Doxorubicin and Indocyanine Green: A Synergistic Cancer Photothermal and Chemotherapeutic Approach
Hui Li, Yuan Fan, Yizhe Shen, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 19, pp. 25101-25112
Closed Access | Times Cited: 3
Hui Li, Yuan Fan, Yizhe Shen, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 19, pp. 25101-25112
Closed Access | Times Cited: 3
Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer
Ruoyi Wang, Xu Huang, Xiaoxi Chen, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 6, pp. 3568-3598
Open Access | Times Cited: 3
Ruoyi Wang, Xu Huang, Xiaoxi Chen, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 6, pp. 3568-3598
Open Access | Times Cited: 3
Synergistic Combination of Oral Transcytotic Nanomedicine and Histone Demethylase Inhibitor for Enhanced Cancer Chemoimmunotherapy
Jing Zhang, Qiuyu Wei, Ying Piao, et al.
ACS Nano (2024)
Closed Access | Times Cited: 2
Jing Zhang, Qiuyu Wei, Ying Piao, et al.
ACS Nano (2024)
Closed Access | Times Cited: 2
Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?
Claudia Giannotta, Federica Autino, Massimo Massaia
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Claudia Giannotta, Federica Autino, Massimo Massaia
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
A single magnetic nanoplatform-mediated combination therapy of immune checkpoint silencing and magnetic hyperthermia for enhanced anti-cancer immunity
Zhiyu Yang, Xiaoya Guo, Meng Meng, et al.
Nano Research (2023) Vol. 16, Iss. 8, pp. 11206-11215
Closed Access | Times Cited: 6
Zhiyu Yang, Xiaoya Guo, Meng Meng, et al.
Nano Research (2023) Vol. 16, Iss. 8, pp. 11206-11215
Closed Access | Times Cited: 6
GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis
Jie Xiong, Yuting Dai, Wenfang Wang, et al.
Science Bulletin (2023) Vol. 68, Iss. 21, pp. 2607-2619
Open Access | Times Cited: 4
Jie Xiong, Yuting Dai, Wenfang Wang, et al.
Science Bulletin (2023) Vol. 68, Iss. 21, pp. 2607-2619
Open Access | Times Cited: 4
Preclinical efficacy of carfilzomib in BRAF‐mutant colorectal cancer models
Federica Maione, Daniele Oddo, Federica Galvagno, et al.
Molecular Oncology (2024) Vol. 18, Iss. 6, pp. 1552-1570
Open Access | Times Cited: 1
Federica Maione, Daniele Oddo, Federica Galvagno, et al.
Molecular Oncology (2024) Vol. 18, Iss. 6, pp. 1552-1570
Open Access | Times Cited: 1
The multifaceted perspectives on the regulation of lncRNAs in hepatocellular carcinoma ferroptosis: from bench-to-bedside
Xin Jin, C. Huang, Yue Tian
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Xin Jin, C. Huang, Yue Tian
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Chimeric peptide-engineered immunostimulant for endoplasmic reticulum targeted photodynamic immunotherapy against metastatic tumor
Rongrong Zheng, Yang Ni, Qiuyuan Li, et al.
Journal of Controlled Release (2024) Vol. 374, pp. 230-241
Closed Access | Times Cited: 1
Rongrong Zheng, Yang Ni, Qiuyuan Li, et al.
Journal of Controlled Release (2024) Vol. 374, pp. 230-241
Closed Access | Times Cited: 1
